Cargando…

Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLR

Hyperlipidemia is considered one of the greatest risk factors of cardiovascular diseases. We investigated the anti-hyperlipidemic effect and the underlying mechanism of wedelolactone, a plant-derived coumestan, in HepG2 cells and high-fat diet (HFD)−induced hyperlipidemic hamsters. We showed that in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yun, Peng, Lu, Yang, Li-chao, Xu, Xu-dong, Li, Wei-jie, Luo, Xiu-mei, Jin, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500417/
https://www.ncbi.nlm.nih.gov/pubmed/26168156
http://dx.doi.org/10.1371/journal.pone.0132720

Ejemplares similares